Mével Elsa, Monfoulet Laurent-Emmanuel, Merceron Christophe, Coxam Véronique, Wittrant Yohann, Beck Laurent, Guicheux Jérôme
INSERM, UMR 791, Skeletal Tissue Engineering and Physiopathology team LIOAD, Nantes, France; Union Grap'Sud, Cruviers-Lascours, France; Université de Nantes, UFR Odontologie, Nantes, France.
Université d'Auvergne, Unité de Nutrition Humaine, Clermont-Ferrand, France; INRA, UMR 1019, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.
Drug Discov Today. 2014 Oct;19(10):1649-58. doi: 10.1016/j.drudis.2014.06.012. Epub 2014 Jun 20.
Osteoarthritis (OA) is a degenerative joint disease with no curative treatments. Many studies have begun to demonstrate the efficacy of nutraceuticals for slowing down OA. Animal models are utilized as a compulsory step in demonstrating the protective potential of these compounds on joint health. Nevertheless, there exist a wide variety of available OA models and selecting a suitable system for evaluating the effects of a specific compound remains difficult. Here, we discuss animal studies that have investigated nutraceutical effects on OA. In particular, we highlight the large spectrum of animal models that are currently accepted for examining the OA-related effects of nutraceuticals, giving recommendations for their use.
骨关节炎(OA)是一种无法治愈的退行性关节疾病。许多研究已开始证明营养保健品对减缓骨关节炎的疗效。动物模型被用作证明这些化合物对关节健康保护潜力的必要步骤。然而,存在各种各样可用的骨关节炎模型,选择一个合适的系统来评估特定化合物的效果仍然很困难。在此,我们讨论了研究营养保健品对骨关节炎影响的动物研究。特别是,我们重点介绍了目前被认可用于研究营养保健品与骨关节炎相关作用的多种动物模型,并给出了使用建议。